The effect of pharmacological treatment on ADMA in patients with heart failure

Graziano Riccioni, Lorenza Speranza, Luca Scotti, Valentina Bucciarelli, Emanuela Di Ilio, Nicolantonio D'Orazio, Mirko Pesce, Antonio Aceto, Valeria Sorrenti, Alessandro Frigiola, Tonino Bucciarelli

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Asymmetric dimethylarginine (ADMA) plays a crucial role in the arginine-nitric oxide (NO) pathway. NO plays an important role in controlling vascular tone and regulates the contractile properties of cardiac myocytes. The purpose of this study was to investigate the effect of pharmacological treatment on asymmetrical dimethylarginine (ADMA) plasma levels in patients with acute congestive heart failure (HF). Patients with symptomatic acute congestive HF (NYHA Class III-IV) and impaired left ventricular (LV) function (ejection fraction <40%) were included in the study. ADMA and SDMA concentrations were assessed before and after pharmacological treatment in 18 critically ill patients on the intensive care unit by high performance liquid chromatography. All patients received a complete pharmacological treatment (diuretics, digoxin, ACE-inhibitors or angiotensin receptor blockers, and nitroglicerin) for the treatment of acute congestive HF. ADMA plasma levels of critically ill patients were significantly higher after pharmacological treatment respect baseline values (pre-treatment). In critically ill patients with acute congestive HF acute renal impairment function and the modulation of NOS determine plasma ADMA/SDMA levels after therapy.

Original languageEnglish
Pages (from-to)1310-1314
Number of pages5
JournalFrontiers in Bioscience - Elite
Volume3 E
Issue number4
Publication statusPublished - Jun 1 2011

Fingerprint

Heart Failure
Space division multiple access
Pharmacology
Plasmas
Critical Illness
Nitric Oxide
Intensive care units
Angiotensin Receptor Antagonists
Digoxin
High performance liquid chromatography
Therapeutics
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Arginine
Modulation
N,N-dimethylarginine
Left Ventricular Function
Cardiac Myocytes
Stroke Volume
Blood Vessels

Keywords

  • ADMA
  • Asymmetric dimethylarginine
  • Heart failure
  • Pulmonary oedema

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Riccioni, G., Speranza, L., Scotti, L., Bucciarelli, V., Ilio, E. D., D'Orazio, N., ... Bucciarelli, T. (2011). The effect of pharmacological treatment on ADMA in patients with heart failure. Frontiers in Bioscience - Elite, 3 E(4), 1310-1314.

The effect of pharmacological treatment on ADMA in patients with heart failure. / Riccioni, Graziano; Speranza, Lorenza; Scotti, Luca; Bucciarelli, Valentina; Ilio, Emanuela Di; D'Orazio, Nicolantonio; Pesce, Mirko; Aceto, Antonio; Sorrenti, Valeria; Frigiola, Alessandro; Bucciarelli, Tonino.

In: Frontiers in Bioscience - Elite, Vol. 3 E, No. 4, 01.06.2011, p. 1310-1314.

Research output: Contribution to journalArticle

Riccioni, G, Speranza, L, Scotti, L, Bucciarelli, V, Ilio, ED, D'Orazio, N, Pesce, M, Aceto, A, Sorrenti, V, Frigiola, A & Bucciarelli, T 2011, 'The effect of pharmacological treatment on ADMA in patients with heart failure', Frontiers in Bioscience - Elite, vol. 3 E, no. 4, pp. 1310-1314.
Riccioni G, Speranza L, Scotti L, Bucciarelli V, Ilio ED, D'Orazio N et al. The effect of pharmacological treatment on ADMA in patients with heart failure. Frontiers in Bioscience - Elite. 2011 Jun 1;3 E(4):1310-1314.
Riccioni, Graziano ; Speranza, Lorenza ; Scotti, Luca ; Bucciarelli, Valentina ; Ilio, Emanuela Di ; D'Orazio, Nicolantonio ; Pesce, Mirko ; Aceto, Antonio ; Sorrenti, Valeria ; Frigiola, Alessandro ; Bucciarelli, Tonino. / The effect of pharmacological treatment on ADMA in patients with heart failure. In: Frontiers in Bioscience - Elite. 2011 ; Vol. 3 E, No. 4. pp. 1310-1314.
@article{0adf49e6ad214b98a500ed8846a319ed,
title = "The effect of pharmacological treatment on ADMA in patients with heart failure",
abstract = "Asymmetric dimethylarginine (ADMA) plays a crucial role in the arginine-nitric oxide (NO) pathway. NO plays an important role in controlling vascular tone and regulates the contractile properties of cardiac myocytes. The purpose of this study was to investigate the effect of pharmacological treatment on asymmetrical dimethylarginine (ADMA) plasma levels in patients with acute congestive heart failure (HF). Patients with symptomatic acute congestive HF (NYHA Class III-IV) and impaired left ventricular (LV) function (ejection fraction <40{\%}) were included in the study. ADMA and SDMA concentrations were assessed before and after pharmacological treatment in 18 critically ill patients on the intensive care unit by high performance liquid chromatography. All patients received a complete pharmacological treatment (diuretics, digoxin, ACE-inhibitors or angiotensin receptor blockers, and nitroglicerin) for the treatment of acute congestive HF. ADMA plasma levels of critically ill patients were significantly higher after pharmacological treatment respect baseline values (pre-treatment). In critically ill patients with acute congestive HF acute renal impairment function and the modulation of NOS determine plasma ADMA/SDMA levels after therapy.",
keywords = "ADMA, Asymmetric dimethylarginine, Heart failure, Pulmonary oedema",
author = "Graziano Riccioni and Lorenza Speranza and Luca Scotti and Valentina Bucciarelli and Ilio, {Emanuela Di} and Nicolantonio D'Orazio and Mirko Pesce and Antonio Aceto and Valeria Sorrenti and Alessandro Frigiola and Tonino Bucciarelli",
year = "2011",
month = "6",
day = "1",
language = "English",
volume = "3 E",
pages = "1310--1314",
journal = "Frontiers in Bioscience - Elite",
issn = "1945-0494",
publisher = "Frontiers in Bioscience",
number = "4",

}

TY - JOUR

T1 - The effect of pharmacological treatment on ADMA in patients with heart failure

AU - Riccioni, Graziano

AU - Speranza, Lorenza

AU - Scotti, Luca

AU - Bucciarelli, Valentina

AU - Ilio, Emanuela Di

AU - D'Orazio, Nicolantonio

AU - Pesce, Mirko

AU - Aceto, Antonio

AU - Sorrenti, Valeria

AU - Frigiola, Alessandro

AU - Bucciarelli, Tonino

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Asymmetric dimethylarginine (ADMA) plays a crucial role in the arginine-nitric oxide (NO) pathway. NO plays an important role in controlling vascular tone and regulates the contractile properties of cardiac myocytes. The purpose of this study was to investigate the effect of pharmacological treatment on asymmetrical dimethylarginine (ADMA) plasma levels in patients with acute congestive heart failure (HF). Patients with symptomatic acute congestive HF (NYHA Class III-IV) and impaired left ventricular (LV) function (ejection fraction <40%) were included in the study. ADMA and SDMA concentrations were assessed before and after pharmacological treatment in 18 critically ill patients on the intensive care unit by high performance liquid chromatography. All patients received a complete pharmacological treatment (diuretics, digoxin, ACE-inhibitors or angiotensin receptor blockers, and nitroglicerin) for the treatment of acute congestive HF. ADMA plasma levels of critically ill patients were significantly higher after pharmacological treatment respect baseline values (pre-treatment). In critically ill patients with acute congestive HF acute renal impairment function and the modulation of NOS determine plasma ADMA/SDMA levels after therapy.

AB - Asymmetric dimethylarginine (ADMA) plays a crucial role in the arginine-nitric oxide (NO) pathway. NO plays an important role in controlling vascular tone and regulates the contractile properties of cardiac myocytes. The purpose of this study was to investigate the effect of pharmacological treatment on asymmetrical dimethylarginine (ADMA) plasma levels in patients with acute congestive heart failure (HF). Patients with symptomatic acute congestive HF (NYHA Class III-IV) and impaired left ventricular (LV) function (ejection fraction <40%) were included in the study. ADMA and SDMA concentrations were assessed before and after pharmacological treatment in 18 critically ill patients on the intensive care unit by high performance liquid chromatography. All patients received a complete pharmacological treatment (diuretics, digoxin, ACE-inhibitors or angiotensin receptor blockers, and nitroglicerin) for the treatment of acute congestive HF. ADMA plasma levels of critically ill patients were significantly higher after pharmacological treatment respect baseline values (pre-treatment). In critically ill patients with acute congestive HF acute renal impairment function and the modulation of NOS determine plasma ADMA/SDMA levels after therapy.

KW - ADMA

KW - Asymmetric dimethylarginine

KW - Heart failure

KW - Pulmonary oedema

UR - http://www.scopus.com/inward/record.url?scp=79960991697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960991697&partnerID=8YFLogxK

M3 - Article

C2 - 21622137

AN - SCOPUS:79960991697

VL - 3 E

SP - 1310

EP - 1314

JO - Frontiers in Bioscience - Elite

JF - Frontiers in Bioscience - Elite

SN - 1945-0494

IS - 4

ER -